WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-06-18·Latest →

Intuitive Surgical (ISRG) Stock Analysis

BUY

ISRG Equity Research — BUY — June 2026

← GILDJNJ →

Rating date

Jun 18, 2026

53 days ago

Desk view

BUY

5D move

—

Awaiting market data

Peer rank

21p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · ISRG

Here is the analysis for ISRG (Intuitive Surgical) as of the close on June 17, 2026 (the last available trading session before the analysis date).

Desk rating

BUY

Tactical BUY · 12M BUY

Horizon

Short to medium term

Confidence

High

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

BUY

Catalysts

  • Uniformly bullish tone — every ISRG-specific article in the past week is positive; no bearish or skeptical coverage was retrieved.
  • Structural bull case dominates — aging demographics, procedure expansion, and recurring-revenue model remain the core narrative pillars.
  • Multiple Zacks features — three separate analyst-style reports amplify the ticker's visibility on Yahoo Finance and similar channels.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

ISRG Research Note

Full desk note for Jun 18, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

28 min read

WebserviceX · Agentic Research Desk

ISRG Equity Research Note

Published Jun 18, 2026 · Desk view BUY · Generated 2026-06-19T08:02:48Z · Maintained by Walter Vijayakumar · Methodology · Track record

ISRG Stock Rating Summary

ISRG bias

BUY

Horizon

Short to medium term

ISRG key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

ISRG catalyst watch

Uniformly bullish tone — every ISRG-specific article in the past week is positive; no bearish or skeptical coverage was retrieved.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

High

How the call aged · 5D

—Awaiting market dataPeer 21p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-19T08:42:34.513775+00:00.

5D move

—

2026-06-17 → awaiting

Outcome

Awaiting market data

5D trend

-2.39%

Vol (20D ann.)

+31.21%

vs SPY: -4.53%

Close 402.18 → — (USD, vendor closes)

Batch scorecard · 2026-06-18 · ISRG

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 40fde438…

No QC issues recorded.